Document Detail

Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. I. Effects of doses and infusion rate on blood pressure, heart rate and plasma histamine concentration.
MedLine Citation:
PMID:  9635499     Owner:  NLM     Status:  MEDLINE    
T-3762, a newly developed fluoroquinolone antimicrobial agent, ciprofloxacin (CPFX) and ofloxacin (OFLX) were administered intravenously to anesthetized dogs by intravenous infusion, and blood pressure, heart rate and plasma histamine concentrations were monitored. T-3762 decreased blood pressure by 12.0%, without alterations in heart rate and plasma histamine concentration, only when infused at 150 mg/min. CPFX and OFLX both produced a rapid decrease in blood pressure in a dose-related manner, with an accompanying decrease in heart rate, but to a lesser extent. After infusion at 150 mg/min, CPFX caused death in 2 animals within a few minutes, while OFLX produced maximum decreases in blood pressure and heart rate, by 69.0% and 26.4%, respectively. The infusion of these 2 agents resulted in dose-related increases in plasma histamine concentrations parallel to the decreases in blood pressure: the maximum, attained with CPFX at 50 mg/min and OFLX at 150 mg/min, were 379.2 and 167.8 ng/ml, respectively. For CPFX and OFLX, the relationship between the maximum levels of decreased blood pressure and increased histamine concentration in plasma was highly significant. The hypotension induced by CPFX was efficiently reduced by the pretreatment of animals with antihistamines. The results from this study suggest that hypotension induced in dogs following the intravenous infusion of fluoroquinolone antimicrobial agents may be dependent on their ability to cause histamine release from cells and tissues, and indicates that T-3762 is devoid of this ability in comparison to CPFX and OFLX.
K Furuhata; H Hayakawa; K Soumi; H Arai; Y Watanabe; H Narita
Related Documents :
1567039 - Reversal of electrophysiologic and hemodynamic effects induced by high dose of bupivaca...
1683249 - Studies with abanoquil (uk-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: i...
7138149 - Effect of clonidine and propranolol on venous smooth muscle from spontaneously hyperten...
3668589 - Clinical parameters of adolescent hispanic male hypertensive subjects: a new subject?
541039 - Clonidine and carotid baroreflex in essential hypertension.
1354539 - Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist,...
23726159 - Blood-pressure targets in patients with recent lacunar stroke: the sps3 randomised trial.
6341219 - The role of renin substrate in hypertension.
3338119 - Facilitating effect of cold shock on recovery from anoxia-induced contractile depressio...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Biological & pharmaceutical bulletin     Volume:  21     ISSN:  0918-6158     ISO Abbreviation:  Biol. Pharm. Bull.     Publication Date:  1998 May 
Date Detail:
Created Date:  1998-08-24     Completed Date:  1998-08-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9311984     Medline TA:  Biol Pharm Bull     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  456-60     Citation Subset:  IM    
Research Laboratories, Toyama Chemical Co., Ltd., Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Infective Agents / administration & dosage,  pharmacology*
Blood Pressure / drug effects*
Ciprofloxacin / pharmacology
Dose-Response Relationship, Drug
Heart Rate / drug effects*
Histamine / blood
Histamine Antagonists / pharmacology
Histamine Release / drug effects*
Infusions, Intravenous
Ofloxacin / pharmacology
Reg. No./Substance:
0/Anti-Infective Agents; 0/Fluoroquinolones; 0/Histamine Antagonists; 0/T 3762; 51-45-6/Histamine; 82419-36-1/Ofloxacin; 85721-33-1/Ciprofloxacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duode...
Next Document:  Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous...